This company seems to have been delisted
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
KemPharm
KMPH
HK$45.61
Share price
-0.34%
Change (1 day)
7.12%
Change (1 year)
Categories
KemPharm (KMPH) - Total assets
Total assets on the balance sheet as of December 2022 : HK$0.90 Billion
According to KemPharm's latest financial reports the company's total assets are HK$0.90 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
KemPharm - Total assets on balance sheet (from 2014 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | HK$0.90 B | -12.92% |
| 2021-12-31 | HK$1.03 B | 1092.96% |
| 2020-12-31 | HK$86.89 M | 6.19% |
| 2019-12-31 | HK$81.82 M | -60.93% |
| 2018-12-31 | HK$0.20 B | -48.9% |
| 2017-12-31 | HK$0.40 B | -37.74% |
| 2016-12-31 | HK$0.65 B | 52.41% |
| 2015-12-31 | HK$0.43 B | 306.03% |
| 2014-12-31 | HK$0.10 B | 464.74% |
| 2013-12-31 | HK$18.83 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | HK$90.54 B | 9,884.25% | 🇮🇪 Ireland |
 Agile Therapeutics
AGRX | HK$0.11 B | -87.05% | 🇺🇸 USA |
 Theravance Biopharma
TBPH | HK$2.69 B | 197.40% | Cayman Islands |
 ANI Pharmaceuticals ANIP | HK$10.14 B | 1,018.71% | 🇺🇸 USA |